Health Policy Associates

What Health Policy Associates does

Health Policy Associates Inc. (HPA) is a privately held regulatory and clinical consulting firm founded in 1992 by Vincent A. Bucci and headquartered in Dedham, Massachusetts. The firm serves medical device, biotechnology, and pharmaceutical companies developing regulated products, providing end-to-end support across seven core service modules: Clinical Trial Strategy and Execution (protocol design, site management, monitoring, biostatistics, SAS programming); Data Management and Analysis (customized database development, EDC integration via a partnership with MedNet Solutions, CDISC-compliant CRF design, SDTM/ADaM conversion, clinical report writing); IRO/Data Integrity Auditing (third-party auditor for FDA Application Integrity Policy cases since 1993, with 35+ submissions); Quality Systems and Compliance Consulting (ISO 13485-aligned QMS development, CAPA, design control, 483/Warning Letter response); Worldwide Regulatory Consulting (FDA, CE Mark, and global submissions including 510(k), IDE, PMA, BLA, NDA, IND); US FDA GMP Auditing Services; and Venture Capital Investing services (due diligence and portfolio oversight for med-device/biotech VCs).

The firm's commercial model is professional services delivered through project-based engagements and retainers, with quote-based, non-public pricing. Customer segments are split between (i) medical device companies and biotech/pharmaceutical firms seeking regulatory and clinical execution support as primary clients, and (ii) venture capital and private equity firms seeking due diligence as a secondary segment. Therapeutic area expertise spans aesthetic devices, wound care, cardiovascular technologies, biologics and stem cell treatments, drug-delivery combination products, orthopedics, and ophthalmic therapies. HPA is differentiated by its 30+ year FDA submission track record, embedded relationships with FDA reviewers, and founder-level ties to the medical device venture capital community. The firm operates from four U.S. locations (Dedham, Austin, San Antonio, Hopatcong), with stated service reach across the USA, Australia, India, China, Brazil, and Japan. No external institutional funding, no parent company, no subsidiaries, and no M&A activity are disclosed; the firm remains wholly founder-owned under CEO Vincent A. Bucci.

Name

Health Policy Associates

Legal name

Health Policy Associates Inc

Website

https://healthpolicyassociates.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

Health Policy Associates is a U.S.-based regulatory and clinical consulting firm serving medical device, biotechnology, and pharmaceutical companies with trial execution, data management, FDA submissions, quality systems, and VC due diligence support, founded in 1992.

Ownership category

akta.pro rank

Product category

Regulatory and Clinical Consulting

SIC

Services-Health Services (8000)

akta.pro primary industry

Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

akta.pro secondary industries

Clinical Trials Authorization & Oversight (GCP) (HLAJADAF), Regulatory Affairs, Labeling & Advertising/Promotion Compliance (HLAJADAI), Health, Pharmaceuticals & Medical Devices Regulatory Cooperation (BPADANAJ)

Keywords

• Regulatory consulting services
• Clinical trial consulting
• FDA submission support
• Medical device consulting
• Quality systems compliance

Headquarters

HQ city

Westwood

HQ country

United States

HQ region

North America

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Regulatory and Clinical Consulting Services: Professional consulting services provided to medical device, biotechnology, and pharmaceutical companies. Services include clinical trial strategy and execution, data management and analysis, regulatory consulting, quality systems compliance, and FDA GMP auditing. Revenue is generated through project-based engagements and retainer arrangements for ongoing consulting support.
2. Venture Capital Due Diligence Services: Providing due diligence services to venture capital firms evaluating investment opportunities in medical device and biotechnology space. Includes analysis of regulatory, clinical, and R&D development plans.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Health Policy Associates provides regulatory and clinical consulting services to medical device, pharmaceutical, and biotechnology companies. The firm guides clients through FDA and international regulatory submissions (IDE, IND, NDA, 510(k), BLA, PMA), clinical trial design and execution, data management and biostatistics, quality systems and GMP compliance, and independent FDA Application Integrity Policy auditing. It also offers due diligence and bridge services connecting medical device and biotech ventures with the venture capital community.

Product overview

Health Policy Associates (HPA) is a regulatory and clinical consulting firm providing end-to-end services for medical device, pharmaceutical, and biologic product development. The company operates as a unified consulting practice offering seven core service modules: Clinical Trial Strategy and Execution (protocol design, site management, monitoring, biostatistics, SAS programming), Data Management and Analysis (customized database development, EDC systems, CDISC-compliant data handling), IRO/Data Integrity Auditing (FDA AIP compliance), Quality Systems/Compliance Consulting, Worldwide Regulatory Consulting (submissions to FDA, CE Mark, and global markets), US FDA GMP Auditing Services, and Venture Capital Investing services. These services work together to guide clients from product concept through commercialization, with particular expertise in aesthetic devices, biologics/stem cell treatments, wound care, and cardiovascular technologies.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trial Strategy and Execution

Quantifiable outcome

• Successfully shepherded numerous IDE, IND, NDA, 510(k), BLA, and PMA applications through FDA
• +2 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• MedNet SolutionscoreTechnology or Integration · 1 January 2016MedNet Solutions is a leading healthcare technology company specializing in electronic data solutions for the global life sciences community. HPA partners with MedNet as a proud partner, leveraging their cloud-based eClinical systems for electronic data capture (EDC) to improve efficiency of clinical studies and registries. Since 2001, MedNet has provided trusted technology innovation for pharmaceutical, medical device, biotechnology and CRO clients worldwide.

Scale indicators3 records

Recent moves4 records

Expansion highlights5 records

Broad incumbents

• Parexel: Global clinical research and regulatory consulting organization serving biopharmaceutical and medical device companies across the full development lifecycle — competing with HPA on FDA submission strategy and clinical consulting.
• ICON plc: Global CRO with a regulatory and clinical consulting arm serving biotech, pharma, and medical device sponsors — a broad incumbent providing overlapping services to HPA's target customers.
• IQVIA: Global CRO and life sciences services firm with a deep regulatory consulting practice and clinical trial operations — competes with HPA for biotech and device sponsors seeking integrated regulatory and clinical solutions.
• Charles River Laboratories: Large CRO offering end-to-end preclinical, clinical, and regulatory services to medical device and biopharma sponsors — a broad incumbent competing with HPA on regulatory strategy and clinical consulting engagements.

Direct peers

• NAMSA: Medical device-focused CRO and regulatory consulting organization offering FDA submission support, clinical trial services, and quality system compliance — a closely comparable peer in the medtech regulatory advisory space.
• Biologics Consulting Group: Specialty regulatory and quality consulting firm focused on biologics, vaccines, and cell/gene therapies — directly comparable to HPA in providing FDA submission strategy, IND/BLA support, and quality systems consulting to biotech sponsors.
• The Weinberg Group: FDA regulatory consulting firm serving pharmaceutical, biologic, and medical device companies on submission strategy, quality systems, and FDA interactions — a direct comparably-sized peer in regulatory advisory.
• Medical Device Consultants (MDCI): Specialized regulatory affairs and quality systems consulting firm serving medical device and IVD manufacturers with FDA and international submissions — a closely aligned boutique peer to HPA's medtech regulatory practice.
• RCRI (now RCG Global Services / legacy RCRI): Medical device regulatory and quality consulting firm historically focused on FDA submissions, QSR compliance, and clinical study support — overlapping heavily with HPA's core medical device regulatory practice.

Others

• McKinsey & Company (Healthcare Practice): Global strategy consulting firm with a major healthcare and life sciences practice advising biotech and medtech clients on regulatory strategy and R&D portfolio decisions — an adjacent advisor rather than direct regulatory execution competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/health-policy-associates-inc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Health Policy Associates